These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20800454)

  • 1. Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease.
    Kawashima T; Tada Y; Asano Y; Yazawa N; Tomita M; Tamaki Z; Kubo M; Ihn H; Sugaya M; Kadono T; Tamaki K; Sato S
    J Dermatol Sci; 2010 Oct; 60(1):52-4. PubMed ID: 20800454
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.
    Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T
    Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
    J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
    Chen YJ; Wu CY; Shen JL
    Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease.
    Sugimoto T; Hajiro T; Fujimoto T; Kojyo N; Horie M; Kashiwagi A
    Lupus; 2007; 16(12):1004-5. PubMed ID: 18042598
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury.
    Miyazaki E; Nureki S; Ono E; Ando M; Matsuno O; Fukami T; Ueno T; Kumamoto T
    Chest; 2007 Jun; 131(6):1726-34. PubMed ID: 17565019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interstial pneumonia, which activity was reflected on KL-6, associated with dermatomyositis successfully treated with cyclosporin A].
    Niinaka M; Matsui K; Aizawa N; Tominaga K; Iida S; Nakano T; Hada T
    Arerugi; 2003 Jul; 52(7):586-90. PubMed ID: 12928607
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
    Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
    J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
    Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
    J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].
    Isoda K; Takeuchi T; Kotani T; Hata K; Shoda T; Ishida T; Yoshida S; Kimura Y; Makino S; Hanafusa T
    PLoS One; 2014; 9(2):e89610. PubMed ID: 24586910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.
    Oda K; Kotani T; Takeuchi T; Ishida T; Shoda T; Isoda K; Yoshida S; Nishimura Y; Makino S
    Sci Rep; 2017 May; 7(1):1635. PubMed ID: 28487565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of nonspecific interstitial pneumonia associated with amyopathic dermatomyositis efficiently treated with a combination of cyclosporin A and prednisolone].
    Ohmichi M; Sasaki-Date H; Morikawa Y; Harada H; Hiraga Y; Inoue N; Shijubo N; Takahashi H; Abe S
    Nihon Kokyuki Gakkai Zasshi; 2002 Jun; 40(6):478-83. PubMed ID: 12325332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/dermatomyositis.
    Wong RC; Klingberg S; Wilson R
    J Rheumatol; 2002 Sep; 29(9):2021-2; author reply 2022. PubMed ID: 12233905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].
    Toyoshima M; Sato A; Chida K; Hayakawa H; Todate A; Imokawa S; Iwata M; Ohashi H; Shirai M; Yagi H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):281-7. PubMed ID: 9168643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukin 15 in patients with rheumatic diseases.
    Suzuki J; Morimoto S; Amano H; Tokano Y; Takasaki Y; Hashimoto H
    J Rheumatol; 2001 Nov; 28(11):2389-91. PubMed ID: 11708407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    Maeda K; Kimura R; Komuta K; Igarashi T
    Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.